Advertisement
Advertisement
U.S. Markets open in 2 hrs 35 mins
Advertisement
Advertisement
Advertisement
Advertisement

Arcturus Therapeutics Holdings Inc. (ARCT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
39.33+0.79 (+2.05%)
At close: 04:00PM EST
39.33 0.00 (0.00%)
After hours: 05:39PM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 2.81
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 3124.00
52 Week Low 324.87
50-Day Moving Average 341.31
200-Day Moving Average 340.72

Share Statistics

Avg Vol (3 month) 3502.46k
Avg Vol (10 day) 3622.56k
Shares Outstanding 526.32M
Implied Shares Outstanding 6N/A
Float 822.43M
% Held by Insiders 114.91%
% Held by Institutions 174.80%
Shares Short (Sep 29, 2021) 41.93M
Short Ratio (Sep 29, 2021) 44.22
Short % of Float (Sep 29, 2021) 413.57%
Short % of Shares Outstanding (Sep 29, 2021) 47.31%
Shares Short (prior month Aug 30, 2021) 42.46M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Nov 15, 2017
Ex-Dividend Date 4N/A
Last Split Factor 21:7
Last Split Date 3Nov 15, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Jun 29, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,878.45%

Management Effectiveness

Return on Assets (ttm)-34.11%
Return on Equity (ttm)-81.71%

Income Statement

Revenue (ttm)8.7M
Revenue Per Share (ttm)0.35
Quarterly Revenue Growth (yoy)-13.80%
Gross Profit (ttm)-48.31M
EBITDA -162.32M
Net Income Avi to Common (ttm)-163.04M
Diluted EPS (ttm)-3.55
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)433.57M
Total Cash Per Share (mrq)16.47
Total Debt (mrq)68.1M
Total Debt/Equity (mrq)22.28
Current Ratio (mrq)6.19
Book Value Per Share (mrq)15.14

Cash Flow Statement

Operating Cash Flow (ttm)-98.4M
Levered Free Cash Flow (ttm)-40.33M
Advertisement
Advertisement